CCL2 production has been reported to be more inducible in HER2+/ER− breast carcinoma cells compared with HER2+/ER+ cells under EGF/HRG stimulation, and enhanced NF-κB transcription levels were detected in HER2+/ER− breast carcinoma cells (5). This evidence concerns the gene ERBB2 and breast carcinoma.